If you are suffering from the deadly sleep disorder called the obstructive sleep apnea (OSA) then you’re not breathing properly while you sleep because your airflow is blocked repeatedly throughout the night.

Almost one in four men and one in ten women suffer from sleep apnea. There are three different types of sleep apnea but obstructive sleep apnea (OSA) is the most common. And it goes hand-in-hand with type 2 diabetes.

Among all of the sleep disorders, OSA has the strongest association with type 2 diabetes. That’s even taking into account other risk factors, such as weight, sex and age.

The main risk factor for OSA is obesity. Excess weight deposits extra fat around the thorax, reducing chest compliance and functional capacity, while increasing oxygen demand. Read the rest of this entry

Lee A. Surkin, MD is the first medical practice in the state of North Carolina to offer Provent Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea (OSA) to patients in Greenville and throughout North Carolina. Cleared by the US FDA in 2008, Provent Therapy is a simple and effective new treatment option for obstructive sleep apnea. Provent Therapy utilizes the patient’s own breathing to provide clinically proven results in the treatment of OSA.

CPAP (continuous positive airway pressure) is currently the gold standard for treatment of OSA and is extremely effective at treating OSA when worn as directed. However, up to half of all patients are not compliant with CPAP therapy due to the cumbersome nature of the treatment. Provent Therapy was developed to help patients who cannot tolerate CPAP therapy and may benefit from the small non-invasive and effective technology Provent Therapy provides. Read the rest of this entry

Reportlinker.com announces that a new market research report is available in its catalogue:

United States Anesthesia and Respiratory Devices Market Outlook to 2017 – Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

The report provides key market data on the United States Anesthesia and Respiratory Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within eight market categories – Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices and Sleep Apnea Diagnostic Systems. Read the rest of this entry

For patients with severe obstructive sleep apnea, three months of continuous positive airway pressure (CPAP) therapy is associated with reduced blood pressure, and partial reversal of metabolic abnormalities, according to a study published in the Dec. 15 issue of the New England Journal of Medicine.

Surendra K. Sharma, M.D., Ph.D., from the All India Institute of Medical Sciences in New Delhi, and colleagues investigated the effects of CPAP treatment on metabolic syndrome in 86 patients with obstructive sleep apnea syndrome. Patients were assigned to real or sham CPAP for three months, followed by a washout period of one month, and then a crossover to the other intervention for three months. Anthropometric variables, blood pressure, fasting blood glucose levels and lipid profile, insulin resistance, glycated hemoglobin levels, carotid intima-media thickness, and visceral fat were measured before and after each intervention. Read the rest of this entry

Sleep apnea is a dangerous problem that can lead to heart attacks, strokes, excessive daytime sleepiness, short-term memory loss and increases in motor vehicle accidents. It is essential to diagnose and treat sleep apnea. One study showed a 36% decrease in 8 year survival comparing treated and untreated sleep apnea.

A problem frequently experienced is that the cost of health, life and disability insurance policies can increase exponentially following diagnosis of sleep apnea. This is problematic for owners of small businesses and wealthy individuals who utilize life insurance to protect their estates. Read the rest of this entry

People with obstructive sleep apnea are more likely to stick to prescribed treatment when a partner or parent is involved with their treatment, according to a team of sleep researchers.

Obstructive sleep apnea occurs when the upper airway collapses during sleep. It is the most common type of sleep-disordered breathing, and chances of it occurring become more elevated in obese people.

The first line of treatment for sleep apnea is a non-invasive in-home treatment called CPAP, continuous positive airway pressure therapy. However, if patients do not use the equipment properly, or at all, it cannot help. Read the rest of this entry

St. Luke’s Sleep Medicine and Research Center is now enrolling participants in a clinical study to evaluate the safety and effectiveness of the Apnex Hypoglossal Nerve Stimulation (HGNS) System, an implantable device, to treat obstructive sleep apnea (OSA).

“Continuous positive airway pressure (CPAP), which involves a pressurized mask over the nose, is considered the ‘gold standard’ for the treatment of sleep apnea, but many people have difficulty tolerating it,” said Paula Schweitzer, PhD, St. Luke’s Sleep Medicine and Research Center director of research. “This implantable device offers a new approach for those who have not had success with CPAP or other sleep apnea treatments.”

People interested in learning if they qualify for the Apnex Clinical Study may call 888-975-3370 begin_of_the_skype_highlighting            888-975-3370     end_of_the_skype_highlighting or visit stlukes-stl.com/sleep. Qualified participants will receive the medical device and care free of charge.

Patients with mild to moderate obstructive sleep apnea (OSA), a condition in which the airway collapses and blocks breathing for 10 seconds or more, may consider adjustable oral appliances (OAs), devices that fit within the mouth to prevent upper airway collapse, as an effective first-line treatment, according to two studies conducted by sleep medicine specialists from Walter Reed National Military Medical Center (WRNMMC) in Bethesda, Md. 

The retrospective, peer-reviewed studies, published in the December 2011 issue of CHEST, the official journal of the American College of Chest Physicians, and in the current issue of the Journal of Clinical Sleep Medicine (JCSM), the official journal of the American Academy of Sleep Medicine, provide findings on OAs from the largest patient populations studied to date. The studies found that adjustable OAs are nearly as effective as continuous positive airway pressure (CPAP) treatment for patients with a mild form of OSA and are more effective than fixed oral appliances, particularly in patients with moderate to severe OSA. Read the rest of this entry

A recent study by the American Psychiatric Association of Psychiatric  Services concludes a direct connection between sleep apnea and certain  psychiatric conditions. It also points out that the solutions for psychiatric  patients are just as simple as those for all individuals suffering from sleep  apnea. Companies like Rematee provide a solution that is both non-evasive and  ensures side sleeping.

Sleep apnea is a relatively common sleep disorder that causes patients to  stop breathing from 20 seconds to 40 seconds, due to a relaxed and thus  partially collapsed airway. Although it will not outright wake its victims, it  will bring them to a lighter stage of sleep, disrupting the rest and relaxation  needed by the brain, as well as other parts of the body.

Because the brain is so affected by this sleep disorder, much research is  being done as to how it relates to psychiatric conditions.  Studies are showing  that the effects of sleep apnea on certain mental conditions, including that of  Alzheimer’s disease, are actually quite prominent. Read the rest of this entry

Reggie White, Percy Harvin and now Shaquille O’Neal directly affected by  sleep apnea.  With over 18 Million Americans affected by Obstructive Seep  Apnea (OSA), it remains one of the most potentially dangerous sleep  disorders.  Large neck sizes and high body mass put athletes at a higher  risk of having the disorder.  Sleep Group Solutions, a dental continuing education and technology  company offers free screening and testing to all professional athletes,  including the NFL.

“The NFL Program was created to raise awareness of OSA by offering  complementary screening and treatment to professional athletes.  Our  affiliated doctors such as SGS Medical Advisor Dr. Atul Malhotra from Harvard  Medical School has already diagnosed a handful of athletes, and recommended either Oral  Appliance Therapy, or the CPAP.”  says Rani Ben-David, President of Sleep  Group Solutions. Read the rest of this entry

The safety and effectiveness of sleep apnea equipment will be examined,evaluated, and determined with the help of a research study conducted by Winston-Salem Company.

Winston-Salem announced that  it has received approval to begin a clinical study to evaluate the  safety and effectiveness of the Apnex hypoglossal Nerve Stimulation (HGNS) System. The device is used to treat obstructive sleep apnea (OSA).

PMG will be one of the first medical centers in the country to participate in this study. “Many people who suffer from OSA are unable to tolerate existing therapies such as continuous positive airway pressure (CPAP). The HGNS System provides a new approach to the treatment of OSA. This study will help us  further understand what role this device could have in treating the millions of people who suffer from OSA,” said the study’s co-principal investigator. Read the rest of this entry

Apnex Medical, Inc., has received CE Mark approval for its Hypoglossal Nerve Stimulation (HGNS®) System for use by people who suffer from obstructive sleep apnea (OSA). The system was approved for sale in Europe based on the positive results of two clinical studies conducted in the United States and Australia. In those studies, the majority of patients demonstrated a significant reduction in their obstructive sleep apnea as well as substantial improvements in the quality of their sleep, quality of life, and overall health.

“CE Mark approval is an important confirmation of the substantial benefits that patients receive from our HGNS therapy for obstructive sleep apnea and is a key milestone for our company,” said Chas McKhann, Apnex Medical President and CEO. Read the rest of this entry

Harry Cutler, a sleep apnea patient, has been awarded patent protection in the United Kingdom. The patent protects a medical device created initially to treat Mr. Cutler’s own obstructive sleep apnea (OSA) which afflicts from 12% to 25% of the population. The device also reduces or eliminates snoring, one of the primary side effects of OSA. Unlike other oral appliances, it can be used by people with loose teeth, dentures, or no teeth at all, thereby eliminating costly dental preparation. It is being marketed as the “RespireAide Sleep Apnea Solution”.

In this case, necessity was indeed the mother of invention. Underemployed at the time and without insurance, Cutler’s sleep apnea became severe. “I was falling asleep while driving to work, in the middle of the day! I had to do something,” said Cutler.

He researched the condition and began to fashion a solution mostly from items found around the house or purchased from the local hardware and sporting goods stores. “The initial device was somewhat crude, but it did help. Over the following six years, using myself as a test subject, I refined and improved the device with the goal of creating an acceptable combination of comfort and effectiveness. The resultant device bears little resemblance to the original,” he added. Read the rest of this entry

According to the National Institute of Neurological Disorders and Strokes,  Sleep Apnea remains a growing health concern with an estimated 18 million  Americans suffering.  Sleep Group Solutions offers home sleep testing (HST)  devices (and interpretation), which have become a popular way to allow the  sufferer to get tested in the privacy of their own home, no over night stay in a  sleep lab needed.  The results are easily uploaded by the physician/practitioner  to InterpStudies.com for a quick diagnosis  of OSA (Obstructive Sleep Apnea).

Historically, an overnight sleep study in a sleep lab was the only way to  obtain a diagnosis of OSA (Obstructive Sleep Apnea).  Recent advancements in  technology has made its way directly into the consumers hands, creating an  increase in sleep apnea diagnosis.  Read the rest of this entry

The American Sleep Apnea Association has recognized CPAP or Continuous Positive Air Pressure as one of the most effective and reliable therapeutic options for the management of mild to moderate sleep apnea. For restoration of normal breathing, choosing the best mask for CPAP is the most critical concern area, especially for patients who are put on this therapy for the first time.

It involves pumping in pre-measured pressurized air directly in to the lungs. One of the most important components of the equipment set is the mask, also known as the sleep apnea masks, since they carry the pressurized air into the lungs generated by the machine.

Reasons why this component should be purchased carefully

- Comfort and ease of use of the item is of paramount importance. Any discomfort can mean discontinuation of therapy.

- Air leakage can mar the efficacy of the therapy. Therefore the item should be bought only after seriously considering various aspects of usage. This is the only way the user can continue with the therapy and enjoy the benefits. Read the rest of this entry